Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2016

01-04-2016 | Gastrointestinal Oncology

Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)

Authors: Veria Khosrawipour, MD, Tanja Khosrawipour, MD, David Diaz-Carballo, PhD, Eckart Förster, PhD, Jürgen Zieren, MD, Urs Giger-Pabst, MD

Published in: Annals of Surgical Oncology | Issue 4/2016

Login to get access

Abstract

Background

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach to delivering intraperitoneal chemotherapy (IPC) as a pressurized aerosol. One of the assumed advantages is the homogeneous drug distribution in the intraperitoneal cavity compared with conventional liquid in situ chemotherapy. However, to date, the spatial drug distribution pattern of PIPAC has not been investigated in detail.

Methods

Doxorubicin was aerosolized in an ex vivo PIPAC model containing native fresh tissue samples of swine peritoneum at a pressure of 12 mmHg CO2 at 36 °C. In the center of the top cover of the PIPAC chamber, a PIPAC micropump was installed. Tissue specimens were placed as follows: (A) bottom of the plastic box, (B) margin of the aerosol jet covered with a bilaterally open tunnel, (C) side wall, and (D) top cover, respectively. In-tissue doxorubicin penetration was measured using fluorescence microscopy on frozen thin sections.

Results

The depth of doxorubicin penetration was found to be significantly higher in tissues directly exposed to the aerosol jet (A: 215 ± 79 µm) compared with the side wall (C: 77 ± 18 µm; p < 0.01) and the top of the box (D: 65 ± 17 µm; p < 0.01). The poorest penetration was observed for peritoneal tissue covered under a bilaterally open plastic tunnel (B: 34 ± 19 µm; p < 0.001).

Conclusions

The study data suggest that the spatial drug distribution pattern of ex vivo PIPAC is heterogeneous.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sadeghi M, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358–63.CrossRefPubMed Sadeghi M, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358–63.CrossRefPubMed
2.
3.
go back to reference Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–42.CrossRefPubMed Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–42.CrossRefPubMed
4.
go back to reference Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284–92.CrossRefPubMed Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284–92.CrossRefPubMed
5.
go back to reference Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal hyperthermic chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–8.CrossRefPubMed Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal hyperthermic chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–8.CrossRefPubMed
6.
go back to reference Verwaal VJ, bruin S, Boot H, et al. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426–32. Verwaal VJ, bruin S, Boot H, et al. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426–32.
7.
go back to reference Dedrick RL, Myers CE, Bungay PM, et al. Pharmacokinetic rational for the peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978;6:1–11. Dedrick RL, Myers CE, Bungay PM, et al. Pharmacokinetic rational for the peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978;6:1–11.
8.
go back to reference Los G, Mutsaers PH, van der Vijgh WJ, et al. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumor after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res. 1989;49:3380–4.PubMed Los G, Mutsaers PH, van der Vijgh WJ, et al. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumor after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res. 1989;49:3380–4.PubMed
11.
go back to reference Flessner MF. The transport barrier in intraperitoneal therapy (review). Am J Physiol Renal Physiol. 2005;288:433–42.CrossRef Flessner MF. The transport barrier in intraperitoneal therapy (review). Am J Physiol Renal Physiol. 2005;288:433–42.CrossRef
12.
go back to reference Solaß W, Hetzel A, Nadiradze G, et al. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849–55.CrossRefPubMed Solaß W, Hetzel A, Nadiradze G, et al. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849–55.CrossRefPubMed
13.
go back to reference Solaß W; Kerb R, Mürdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21:553–9.CrossRefPubMedPubMedCentral Solaß W; Kerb R, Mürdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21:553–9.CrossRefPubMedPubMedCentral
14.
go back to reference Jacquet P, Stuart OA, Chang D, et al. Effects of intraabdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996;7:596–603.CrossRefPubMed Jacquet P, Stuart OA, Chang D, et al. Effects of intraabdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996;7:596–603.CrossRefPubMed
15.
go back to reference Hinds WC. Aerosol technology. 2nd ed. Hoboken: Wiley-Interscience; 1999. Hinds WC. Aerosol technology. 2nd ed. Hoboken: Wiley-Interscience; 1999.
16.
go back to reference Solaß W, Herbette A, Schwarz T, et al. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012;26:847–52.CrossRefPubMedPubMedCentral Solaß W, Herbette A, Schwarz T, et al. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012;26:847–52.CrossRefPubMedPubMedCentral
17.
go back to reference Rubin BK. Air and soul: the science and application of aerosol therapy. Respir Care. 2010;55:911–21.PubMed Rubin BK. Air and soul: the science and application of aerosol therapy. Respir Care. 2010;55:911–21.PubMed
18.
go back to reference Reymond MA, Solaß W. Pressurized intraperitoneal aerosol chemotherapy—cancer under pressure. 1st ed. Berlin: De Gruyter; 2014. Reymond MA, Solaß W. Pressurized intraperitoneal aerosol chemotherapycancer under pressure. 1st ed. Berlin: De Gruyter; 2014.
Metadata
Title
Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
Authors
Veria Khosrawipour, MD
Tanja Khosrawipour, MD
David Diaz-Carballo, PhD
Eckart Förster, PhD
Jürgen Zieren, MD
Urs Giger-Pabst, MD
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4954-9

Other articles of this Issue 4/2016

Annals of Surgical Oncology 4/2016 Go to the issue